Lipid Disorders
Conference Coverage
Hyperlipidemia diagnosis protects against breast cancer
BARCELONA – Large U.K. study also shows mortality benefit.
From the Journals
CDC: Forty percent of cancers linked to overweight or obesity
Being overweight or obese was associated with a higher risk of at least 13 cancers.
Conference Coverage
LDL levels below 10 mg/dL shown safe, effective
BARCELONA – A FOURIER analysis showed that plunging LDL cholesterol below 10 mg/dL brings events down with it.
From the Journals
VIDEO: Alcohol showed no cardiovascular benefits in nonalcoholic fatty liver disease
Long-term prospective studies are needed to better understand how types and doses of alcohol affect cardiovascular endpoints in patients with...
Conference Coverage
Empagliflozin’s effects independent of CVD risk factors
There is more to empagliflozin than meets the eye, or the risk factors.
Conference Coverage
Higher BP targets suggested for elderly, cognitively impaired
SAN FRANCISCO – The price of lowering blood pressure in the elderly may be cognitive decline and even Alzheimer’s disease, one expert says.
Conference Coverage
RAS derangement linked to CVD risk in adolescents born preterm
SAN FRANCISCO – The renin-angiotensin system is out of balance in adolescents born prematurely.
News
Lomitapide manufacturer will plead guilty to two misdemeanor charges of misbranding
Lomitapide's rare disorder target was portrayed as vague to extend its use to more patients, according to the FDA.
From the Journals
Statin use reduces death and decompensation in cirrhosis patients
More statins, more positive outcomes.
From the Journals
Statins linked to lower death rates in COPD
Researchers explore whether COPD progression results from systemic inflammation.
Conference Coverage
Alirocumab’s ODYSSEY continues: Efficacy unaffected by insulin, beats fenofibrate
LISBON – Lipids in either type of diabetes may have met their match.